NO20075567L - 4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater som medikamenter for behandling av infertilitet - Google Patents
4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater som medikamenter for behandling av infertilitetInfo
- Publication number
- NO20075567L NO20075567L NO20075567A NO20075567A NO20075567L NO 20075567 L NO20075567 L NO 20075567L NO 20075567 A NO20075567 A NO 20075567A NO 20075567 A NO20075567 A NO 20075567A NO 20075567 L NO20075567 L NO 20075567L
- Authority
- NO
- Norway
- Prior art keywords
- oxo
- phenyl
- infertility
- drugs
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05103738 | 2005-05-04 | ||
| PCT/EP2006/061976 WO2006117370A1 (en) | 2005-05-04 | 2006-05-02 | 4-PHENYL-5-OXO-l,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20075567L true NO20075567L (no) | 2007-12-03 |
Family
ID=34939695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20075567A NO20075567L (no) | 2005-05-04 | 2007-11-05 | 4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater som medikamenter for behandling av infertilitet |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8034945B2 (sr) |
| EP (1) | EP1879580B1 (sr) |
| JP (1) | JP5129738B2 (sr) |
| KR (1) | KR20080010427A (sr) |
| CN (1) | CN101212972B (sr) |
| AR (1) | AR056338A1 (sr) |
| AT (1) | ATE424823T1 (sr) |
| AU (1) | AU2006243190B2 (sr) |
| BR (1) | BRPI0611118A2 (sr) |
| CA (1) | CA2606682C (sr) |
| CY (1) | CY1109076T1 (sr) |
| DE (1) | DE602006005640D1 (sr) |
| DK (1) | DK1879580T3 (sr) |
| ES (1) | ES2322295T3 (sr) |
| HR (1) | HRP20090189T1 (sr) |
| IL (1) | IL186676A (sr) |
| MX (1) | MX2007013742A (sr) |
| NO (1) | NO20075567L (sr) |
| NZ (1) | NZ562685A (sr) |
| PE (1) | PE20061440A1 (sr) |
| PL (1) | PL1879580T3 (sr) |
| PT (1) | PT1879580E (sr) |
| RS (1) | RS50968B (sr) |
| RU (1) | RU2403243C2 (sr) |
| SI (1) | SI1879580T1 (sr) |
| UA (1) | UA92008C2 (sr) |
| WO (1) | WO2006117370A1 (sr) |
| ZA (1) | ZA200709094B (sr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1879866T3 (da) * | 2005-05-04 | 2011-06-06 | Organon Nv | Dihydropyridinderivater |
| UA92007C2 (ru) * | 2005-05-04 | 2010-09-27 | Н.В. Органон | Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодности |
| UA92009C2 (ru) * | 2005-05-04 | 2010-09-27 | Н.В. Органон | Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодия |
| TW200944523A (en) | 2008-02-08 | 2009-11-01 | Organon Nv | (Dihydro)pyrrolo[2,1-a]isoquinolines |
| US8071587B2 (en) | 2009-05-27 | 2011-12-06 | N. V. Organon | (Dihydro)imidazoiso[5,1-A]quinolines |
| TW201116531A (en) | 2009-07-29 | 2011-05-16 | Organon Nv | Ring-annulated dihydropyrrolo[2,1-a]isoquinolines |
| US8431564B2 (en) | 2009-07-29 | 2013-04-30 | Merck Sharp & Dohme B.V. | Ring-annulated dihydropyrrolo[2,1-α]isoquinolines |
| TW201116515A (en) | 2009-07-31 | 2011-05-16 | Organon Nv | Dihydrobenzoindazoles |
| WO2011157654A1 (de) | 2010-06-15 | 2011-12-22 | Bayer Cropscience Ag | Anthranilsäurediamid-derivate |
| RU2648352C1 (ru) * | 2017-07-18 | 2018-03-23 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ лечения первичного бесплодия, обусловленного тромбофилиями при проведении экстракорпорального оплодотворения |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1070162B (de) | 1959-12-03 | Farbwerke Hoechst Aktiengesellschaft vormals Meister Lucius &. Brüning, Frankfurt/M | Verfahren zur Herstellung von 5 - Brom - 3 - nitro - 4 - hydroxybenzaldehyd bzw. 5 - Chlor - 3 - nitro - 4 - hydroxybenzaldehyd | |
| US5455253A (en) * | 1992-10-20 | 1995-10-03 | Zeneca Limited | Heterocyclic derivatives |
| GB9318935D0 (en) * | 1992-10-20 | 1993-10-27 | Zeneca Ltd | Heterocyclic derivatives |
| GB9407432D0 (en) * | 1994-04-14 | 1994-06-08 | Zeneca Ltd | Heterocyclic derivative |
| DE4430639A1 (de) * | 1994-08-29 | 1996-03-07 | Bayer Ag | Verwendung von 5-substituierten Pyridin- und Hexahydrochinolin-3-carbonsäurederivaten |
| GB9515445D0 (en) | 1995-07-27 | 1995-09-27 | Pharmacia Spa | Dihydropyridine and pyridine derivatives and process for their preparation |
| AU7333496A (en) * | 1995-10-19 | 1997-05-07 | Takeda Chemical Industries Ltd. | Quinoline derivatives as gnrh antagonists |
| US6593335B1 (en) | 1997-12-18 | 2003-07-15 | Abbott Laboratories | Potassium channel openers |
| ATE279407T1 (de) | 1998-08-07 | 2004-10-15 | Applied Research Systems | Fsh mimetika zur behandlung von infertilität |
| CA2425889A1 (en) | 2000-07-27 | 2002-02-07 | Smithkline Beecham Corporation | Agonists of follicle stimulating hormone activity |
| RU2347570C2 (ru) | 2001-07-02 | 2009-02-27 | Н.В.Органон | Тетрагидрохинолиновые производные |
| JP2003026630A (ja) | 2001-07-13 | 2003-01-29 | Taoka Chem Co Ltd | カラーカプラー中間体用カルボン酸クロリド類の製造法 |
| TWI322012B (en) | 2002-12-20 | 2010-03-21 | Organon Nv | Tetrahydroquinoline derivatives |
| UA92007C2 (ru) | 2005-05-04 | 2010-09-27 | Н.В. Органон | Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодности |
| DK1879866T3 (da) | 2005-05-04 | 2011-06-06 | Organon Nv | Dihydropyridinderivater |
| UA92009C2 (ru) | 2005-05-04 | 2010-09-27 | Н.В. Органон | Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодия |
-
2006
- 2006-02-05 UA UAA200711803A patent/UA92008C2/ru unknown
- 2006-05-02 AT AT06754952T patent/ATE424823T1/de active
- 2006-05-02 JP JP2008509436A patent/JP5129738B2/ja not_active Expired - Fee Related
- 2006-05-02 AU AU2006243190A patent/AU2006243190B2/en not_active Ceased
- 2006-05-02 KR KR1020077026920A patent/KR20080010427A/ko not_active Ceased
- 2006-05-02 WO PCT/EP2006/061976 patent/WO2006117370A1/en not_active Ceased
- 2006-05-02 RS RSP-2009/0251A patent/RS50968B/sr unknown
- 2006-05-02 DE DE602006005640T patent/DE602006005640D1/de not_active Expired - Lifetime
- 2006-05-02 MX MX2007013742A patent/MX2007013742A/es active IP Right Grant
- 2006-05-02 ES ES06754952T patent/ES2322295T3/es not_active Expired - Lifetime
- 2006-05-02 HR HR20090189T patent/HRP20090189T1/xx unknown
- 2006-05-02 SI SI200630269T patent/SI1879580T1/sl unknown
- 2006-05-02 EP EP06754952A patent/EP1879580B1/en not_active Expired - Lifetime
- 2006-05-02 CN CN2006800237472A patent/CN101212972B/zh not_active Expired - Fee Related
- 2006-05-02 PT PT06754952T patent/PT1879580E/pt unknown
- 2006-05-02 BR BRPI0611118-1A patent/BRPI0611118A2/pt not_active IP Right Cessation
- 2006-05-02 DK DK06754952T patent/DK1879580T3/da active
- 2006-05-02 US US11/912,746 patent/US8034945B2/en active Active
- 2006-05-02 RU RU2007144988/04A patent/RU2403243C2/ru not_active IP Right Cessation
- 2006-05-02 NZ NZ562685A patent/NZ562685A/en not_active IP Right Cessation
- 2006-05-02 PL PL06754952T patent/PL1879580T3/pl unknown
- 2006-05-02 CA CA2606682A patent/CA2606682C/en not_active Expired - Fee Related
- 2006-05-03 AR ARP060101780A patent/AR056338A1/es not_active Application Discontinuation
- 2006-05-03 PE PE2006000468A patent/PE20061440A1/es not_active Application Discontinuation
-
2007
- 2007-10-16 IL IL186676A patent/IL186676A/en not_active IP Right Cessation
- 2007-10-22 ZA ZA200709094A patent/ZA200709094B/xx unknown
- 2007-11-05 NO NO20075567A patent/NO20075567L/no not_active Application Discontinuation
-
2009
- 2009-05-19 CY CY20091100532T patent/CY1109076T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20084912L (no) | Bisykliske derivater som CETP-inhibitorer | |
| CY1109076T1 (el) | Παραγωγα της 4- phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline ως φαρμακα για θεραπεια της στειροτητας | |
| NO20083214L (no) | Pyrimidinylarylurea-derivater som omdannes til FGF-inhibitorer | |
| NO20070339L (no) | 1-aza-bicyklo[3 3.1]nonaner | |
| NO20076066L (no) | Oksadiazolderivater som DGAT-inhibitorer | |
| ATE530519T1 (de) | Cyclobutylaminderivate | |
| NO20082445L (no) | Neuropeptid-2 reseptor-agonister | |
| NO20073876L (no) | Pyrazolopyrimidinderivater som mGluR2-antagonister | |
| NO20071245L (no) | Kinazolinonderivater og deres anvendelse som b-RAF-inhibitorer. | |
| NO20051165L (no) | Benzotiazolderivater som har -adrenoerseptorantagonist aktivitet | |
| NO20070714L (no) | 3-(heteroaryl-oksy)-2-alkyl-1-aza-bicykloalkylderivater som alfa-7-nAChR ligander for terapi av CNS-sykdommer | |
| WO2008094992A3 (en) | 2-aminopyridine derivatives useful as kinase inhibitors | |
| NO20076195L (no) | Nye 2-azetidinonderivater for behandling av hyperlipidemiske sykdommer | |
| WO2008060621A3 (en) | Aminopyrrolidines as chemokine receptor antagonists | |
| NO20072747L (no) | Fremgangsmate for fremstilling av indazolforbindelser | |
| NO20062139L (no) | Dihydrobenzofuranyl-alkanaminderivater som 5HT2C-agonister | |
| NO20073571L (no) | Nye hydantoinderivater som metallproteinaseinhibitorer | |
| WO2008115999A8 (en) | Biaryl and biheteroaryl compounds useful in treating iron disorders | |
| NO20080394L (no) | N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav | |
| NO20090282L (no) | Syklopropylaminderivater som histamin H3 reseptormodulatorer | |
| MXPA05004621A (es) | Derivados de anilinopirazol utiles en el tratamiento de la diabetes. | |
| WO2007041077A3 (en) | Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes | |
| NO20082054L (no) | Nye 2-fenylimidazo[4,5-b]pyridinderivater som inhibitorer av glykogensyntasekinase for behandling av demens og neurodegenerative forstyrrelser | |
| NO20080372L (no) | Pyrazolderivater som teraputiske midler | |
| JO2734B1 (en) | Organic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |